128 related articles for article (PubMed ID: 37132314)
1. Clinicomycological Profile and Risk Factors for Dermatophytosis at a Teaching Tertiary Care Centre in North India: A Cross-sectional Study.
Singla P; Garg S; Singh P; Sharma N; Mane P; Singh NK; Sharma S
Infect Disord Drug Targets; 2023; 23(6):e280423216334. PubMed ID: 37132314
[TBL] [Abstract][Full Text] [Related]
2. Clinicomycological Study of Dermatophytosis in South India.
Poluri LV; Indugula JP; Kondapaneni SL
J Lab Physicians; 2015; 7(2):84-9. PubMed ID: 26417157
[TBL] [Abstract][Full Text] [Related]
3. Dermatophytic Infections among the Patients Attending Di Skin Hospital and Research Center at Maharajgunj Kathmandu.
Paudel D; Manandhar S
J Nepal Health Res Counc; 2015; 13(31):226-32. PubMed ID: 27005717
[TBL] [Abstract][Full Text] [Related]
4. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
[TBL] [Abstract][Full Text] [Related]
6. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
[TBL] [Abstract][Full Text] [Related]
7. A Cross-Sectional Clinicomycological Study on Dermatophytosis: A Report From a Single Tertiary Healthcare Center in Eastern India.
Das D; Mondal H; Deb Roy A; Anand A; Maiti P; Ray A
Cureus; 2022 Nov; 14(11):e31728. PubMed ID: 36569693
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological characterization of dermatophytes at a tertiary care hospital in Eastern Uttar Pradesh, India.
Upadhyay V; Kumar A; Singh AK; Pandey J
Curr Med Mycol; 2019 Mar; 5(1):1-6. PubMed ID: 31049451
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological Trends and Clinicomycological Profile of Chronic Dermatophytosis: A Descriptive Study From South India.
Rajamohanan R; Raj R; Chellam J; Rengasamy M
Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759422
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients.
Mathur M; Shrestha S
JNMA J Nepal Med Assoc; 2015; 53(198):108-12. PubMed ID: 26994030
[TBL] [Abstract][Full Text] [Related]
11. A clinical and mycological study of dermatophytic infections.
Surendran K; Bhat RM; Boloor R; Nandakishore B; Sukumar D
Indian J Dermatol; 2014 May; 59(3):262-7. PubMed ID: 24891657
[TBL] [Abstract][Full Text] [Related]
12. Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.
Saha I; Podder I; Chowdhury SN; Bhattacharya S
Indian Dermatol Online J; 2021; 12(5):714-721. PubMed ID: 34667758
[TBL] [Abstract][Full Text] [Related]
13. Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India.
Jain A; Dhamale S; Sardesai V
Mycoses; 2021 Nov; 64(11):1442-1447. PubMed ID: 33966290
[TBL] [Abstract][Full Text] [Related]
14. A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India.
Balasubramanian A; Akbar Ali NA; Pugazhenthi A; Gopalan K; Tamil Selvan S; Ramalingam K
Mycoses; 2024 Feb; 67(2):e13707. PubMed ID: 38366126
[TBL] [Abstract][Full Text] [Related]
15. Clinico-mycological study of onychomycosis in a tertiary care hospital-A cross-sectional study.
Kayarkatte MN; Singal A; Pandhi D; Das S
Mycoses; 2020 Jan; 63(1):113-118. PubMed ID: 31642133
[TBL] [Abstract][Full Text] [Related]
16. Clinicomycological Profile of Pediatric Dermatophytoses: An Observational Study.
Ray A; Singh BS; Kar BR
Indian Dermatol Online J; 2022; 13(3):361-365. PubMed ID: 36225993
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and clinical pattern of dermatomycoses in rural India.
Lakshmanan A; Ganeshkumar P; Mohan SR; Hemamalini M; Madhavan R
Indian J Med Microbiol; 2015 Feb; 33 Suppl():134-6. PubMed ID: 25657132
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Recalcitrant Dermatophytosis in a Multicenter Study in Sri Lanka.
Madarasingha NP; Eriyagama S; Jayasekera PI; de Silva Weliange S; Gunasekera S; Munasingha DM; Rajendran P; Ekanayaka SMB; Liyanange J; Thamilvannan N; Sumanasena B; Srisaravanabavanathan F; Wijenayake B
Am J Trop Med Hyg; 2022 Jul; 107(1):117-121. PubMed ID: 35895368
[TBL] [Abstract][Full Text] [Related]
19. The Current Indian Epidemic of Dermatophytosis: A Study on Causative Agents and Sensitivity Patterns.
Das S; De A; Saha R; Sharma N; Khemka M; Singh S; Hesanoor Reja AH; Kumar P
Indian J Dermatol; 2020; 65(2):118-122. PubMed ID: 32180597
[TBL] [Abstract][Full Text] [Related]
20. Clinico-microbiological study of dermatophytosis in a tertiary-care hospital in North Karnataka.
Noronha TM; Tophakhane RS; Nadiger S
Indian Dermatol Online J; 2016; 7(4):264-71. PubMed ID: 27559499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
